From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer
- 1 November 2018
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 86, 200-205
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyondHead & Neck, 2017
- Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2017
- Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingCancer, 2016
- Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinomaHead & Neck, 2016
- Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaJAMA Oncology, 2015
- Efficacy of Induction Selection Chemotherapy vs Primary Surgery for Patients With Advanced Oral Cavity CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2014
- An international phase 3 trial in head and neck cancer: Quality of life and symptom resultsCancer, 2013
- Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasionThe Laryngoscope, 2009
- Expression of p53 and Bcl-xL as Predictive Markers for Larynx Preservation in Advanced Laryngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2008
- Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neckCancer, 1984